项目 | 对照组 | 康复组 | t/x2 | P值 |
年龄(岁, ) | 52.4 ± 11.7 | 53.7 ± 11.9 | 0.97 | 0.334 |
男性[例(%)] | 21 (50.0) | 19 (45.2) | 0.37 | 0.548 |
BMI (kg/m2, ) | 23.9 ± 3.1 | 22.1 ± 3.3 | 0.44 | 0.662 |
收缩压(mmHg, ) | 128.0 ± 19.4 | 126.1 ± 18.3 | 0.36 | 0.528 |
心率(次/分, ) | 72.2 ± 18.3 | 70.9 ± 19.2 | 2.79 | 0.042 |
氧饱和度(%, ) | 92.3 ± 12.2 | 93.6 ± 13.8 | 0.68 | 0.472 |
吸烟史[例(%)] | 16 (38.1) | 14 (33.3) | 0.45 | 0.5 |
饮酒史[例(%)] | 5 (11.9) | 6 (14.2) | 1.24 | 0.266 |
合并症[例(%)] |
|
|
|
|
高血压 | 15 (28.6) | 16 (38.1) | 0.02 | 0.903 |
糖尿病 | 19 (45.2) | 18 (42.9) | 0.36 | 0.554 |
冠心病 | 28 (66.7) | 26 (61.9) | 0.98 | 0.672 |
合并用药[例(%)] |
|
|
|
|
ACEI/ARB/ARNI | 40 | 41 | 1.96 | 0.168 |
B-受体阻滞剂 | 39 | 37 | 2.01 | 0.752 |
MRA | 38 | 39 | 0.184 | 0.732 |
SGL-T2i | 28 | 27 | 1.96 | 0.178 |
心衰病程(年, ) | 6 ± 2.3 | 5 ± 2.9 | 0.22 | 0.643 |